IPO Size
Price Band
Minimum Lot Size
Face Value
Employee Discount
Retail Allocation
Issue Open Date
Issue Close Date
Listing Date
About the Company:
Rainbow Children’s medicare is a leading multi-specialty pediatric and obstetrics and gynecology hospital chain in India, operating 14 hospitals and three clinics in six cities, with a total bed capacity of 1,500 beds, as of September 30, 2021.
At the Rainbow Children’s Heart Institute, located in Hyderabad, Rainbow dedicated 110 beds for our cardiac program. Since the Heart Institute commenced operations in June 2019 until September 30, 2021, treated 17,995 outpatients and performed 769 cardiac surgeries and 725 cardiac catheterization procedures.
Medicare’s core facilities are specialties are pediatrics, obstetrics, and gynecology.
Medicare established its first pediatric specialty hospital in 1999 in Hyderabad. As of September 30, 2021, medicare had 602 full-time doctors and 1,686 part-time/visiting doctors.
Outstanding Litigation:
| S.No. | Company | Directors | Promoters | |||
| Entity Name | By the Company | Against the Company | By the Director | Against the Director | By the Promoter | Against the Promoter |
| Criminal cases | 1 | 3 | - | - | - | - |
| Material civil cases | 3 | 9 | - | - | - | - |
| Taxation matters | - | - | - | - | - | - |
| Regulatory Proceedings | - | - | - | - | - | - |
Financial Statements:
| Income Statement(in Milllions) | Sep'2021 | FY21 | FY20 | FY19 |
| Gross Operating Income | 5,195.92 | 6,603.10 | 7,297.37 | 5,511.44 |
| Cost of Employee & Inventory | 552.09 | 1,020.94 | 1,089.71 | 857.40 |
| Other Expenses | 3,450.81 | 5,429.09 | 6,157.20 | 4,518.04 |
| EBITDA | 1,745.11 | 1,730.97 | 2,073.73 | 1,568.66 |
| Depreciation | 398.51 | 733.38 | 694.11 | 603.16 |
| Finance Cost | 253.36 | 440.63 | 446.06 | 390.24 |
| Profit Before Tax | 1,093.24 | 556.96 | 933.56 | 575.26 |
| Tax | 281.06 | 161.28 | 380.16 | 129.36 |
| Profit After Tax | 812.18 | 395.68 | 553.40 | 445.90 |
Dr. Ramesh Kancharla, Dr. Dinesh Kumar Chirla, and Dr. Adarsh Kancharla
• Apollo Hospitals Enterprise Limited • Fortis Healthcare Limited • Narayana Hrudalaya Limited • Max Healthcare Institute Limited • Krishna Institute of Medical Sciences Limited
The proceeds from the sale of 2,40,00,000 equity shares by promoters will not be received by the company.
The proceeds from the sale of fresh shares will be utilized for the following: • The Early redemption of NCDs issued by our Company, in full. • Capital expenditure towards setting up of new hospitals and purchase of medical equipment for such new hospitals. • General corporate purposes.
